Umbilical vein and arteries are located in the umbilical cord and surrounded by a dense extracellular matrix named Wharton's jelly. Due to their origin, these tissues are highly available. Nerve lesions or sections are common pathologies + healing can be accelerated by the use of a chamber sleeved or wrapped around the nerve. The goal is to develop from umbilical vessels a biologic conduit, secured and dehydrated to be used as nerve regeneration chamber. The umbilical cord is sampled according to directive 2006 17 CE (clinical and biological donor criteria). The vessels are extracted and inverted to expose to have an internal dense Wharton's jelly that takes part in the tissue holding. The vessels are treated with a disinfectant and virally inactivating chemical process. They are freeze-dried and finally gamma sterilized. Viral and microbiological security of the process are evaluated by spiking 10exp6 viruses strain in the Wharton's jelly and determining their destruction after process application. Biocompatibility tests are carried out according to ISO 10993 standard. Viability and attachment of mesenchymal stem cells (MSC) are conducted. Structural properties of the vessels are determined by staining the main proteins and components. Its physical characteristics are evaluated through its tensile mechanical resistance. In vivo implantation of the product on 1 cm sciatic nerve gap in a rat model evaluates its efficacy as a nerve regeneration chamber. The chemical treatment applied reduces the viral load of enveloped and non-enveloped viruses by more than 4 logs. No strain is recovered after the gamma sterilization. The product meets ISO 10993 requirements. MSC are viable and attached all along the product surface. The process applied enables the preservation of the product structure and the maintenance of the main components, collagen IV, elastin, laminin I and hyaluronic acid. The tensile mechanical resistance of the product is 100 kPa. The in vivo study shows effective nerve regeneration after 8 weeks with presence of early myelinated mature axons from the proximal to the distal stumps and a complete integration of the well-tolerated product. The process applied on the umbilical vessels is secured. The final product presents a physiologic structural integrity and an excellent biocompatibility. The tissue engineering product from inverted umbilical vessels is secured and dehydrated. Due to its physical and biological properties, it is an innovative alternative as nerve regeneration chamber, available in different sizes.